Clinical Trial Detail

NCT ID NCT01949194
Title Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Gerald Batist
Indications

rectum adenocarcinoma

colon adenocarcinoma

colorectal adenocarcinoma

Therapies

Regorafenib

Age Groups: adult

No variant requirements are available.